维普中文期刊产品整合服务
123篇 您的检索式:作者名="Dieplinger"
    题名 作者 年代 出处 被引量
1Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inlammatory bowel disease显示文摘AIM:To determine free and conjugated serum bile acid (BA) levels in in? ammatory bowel disease (IBD) subgroups with defi ned clinical manifestations.METHODS: Comprehensive serum BA profiling was performed in 358 IBD patients and 310 healthy controls by liquid chromatography coupled to electrospray ionization tandem mass spectrometry.RESULTS: Serum levels of hyodeoxycholic acid, the CYP3A4-mediated detoxification product of the secondary BA lithocholic acid (LCA), was increased significantly in Crohn's disease (CD) and ulcerative colitis (UC), while most other serum BA species were decreased significantly. Total BA, total BA conjugate, and total BA glycoconjugate levels were decreased only in CD, whereas total unconjugated BA levels were decreased only in UC. In UC patients with hepatobiliary manifestations, the conjugated primary BAs glycocholic acid, taurocholic acid, and glycochenodeoxycholic acid were as significantly increased as the secondary BAs LCA, ursodeoxycholic acid, and tauroursodeoxycholic acid compared to UC patients without hepatobiliary manifestations. Finally, we found that in ileocecal resected CD patients, the unconjugated primary BAs, cholic acid and chenode-oxycholic acid, were increased significantly compared to controls and patients without surgical interventions.CONCLUSION: Serum BA profiling in IBD patients that indicates impaired intestinal barrier function and increased detoxification is suitable for advanced diagnostic characterization and differentiation of IBD subgroups with defined clinical manifestations.Carsten Gnewuch Gerhard Liebisch Thomas Langmann Benjamin Dieplinger Thomas Mueller Meinhard Haltmayer Hans Dieplinger Alexandra Zahn Wolfgang Stremmel Gerhard Rogler Gerd Schmitz 2009World Journal of Gastroenterology2009,15,25:4
2Prognostic value of established and novel biomarkers in patients with shortness of breath attending an emergency department显示文摘DIEPLINGER B GEGENHUBER A KAAR G 0,,09:1
3A cold-active extracellular metalloprotease from Pedobacter cryoconitisproduction and properties显示文摘Margesin R Dieplinger H Hofmann J 2005Research in Microbiology2005,156,4:1
4Increased plasma concentrations of soluble ST2are predictive for 1-year mortality in patients with acute destabilized heart failure显示文摘Mueller T Dieplinger B Gegenhuber A 2008Clin Chem2008,54,4:1
5Prognostic value of soluble ST2 in an unselected cohort of patients admitted to an intensive care unit-The Linz Intensive Care Unit (LICU) study显示文摘DIEPLINGER B EGGER M KOEHLER W 0,,5:1
6Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and copeptin to predictl-yearmortality in patients with acute destabilized heart failure显示文摘Gegenhuber A Struck J Dieplinger B 2007Card Fail2007,13,:1
7The vitamin E-binding protein afamin increases in maternal serum during pregnancy显示文摘Michael Hubalek Hannes Buchner Manfred G. M?rtl Dietmar Schlembach Berthold Huppertz Branka Firulovic Wolfgang K?hler Erich Hafner Benjamin Dieplinger Ludwig Wildt Hans Dieplinger 2014Clinica Chimica Acta2014,,:1
8Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic pe- ripheral arterial disease: results from the Linz Peripheral Arterial Dis- ease (LIPAD) study显示文摘Dieplinger B Haltmayer M Poelz W 2009Clin Chim Acta2009,408,12:1
9Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure显示文摘Mueller T Dieplinger B Gegenhuber A 2008Clin Chem2008,4,:1
10The Presage ST2 Assay: analytical considerations and clinical applications fora high-sensitivity assay for measurement of soluble ST2 显示文摘Thomas Mueller Benjamin Dieplinger 2003Expert Rev Mol Diagn2003,13,1:1
11The Presage? ST2 Assay: analytieal con- siderations and clinical applications for a high-sensitivity assay for measurement of soluble ST2显示文摘Mueller T Dieplinger t3 2013Expert Rev Mol Diagn2013,13,1:1
12HypoAdiponectininemia is associated with symptomatic atherosclerotic peripheral arterial disease 显示文摘Dieplinger B Poelz W Haltmayer M 2006Clin Chem Lab Med2006,44,7:1
13Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure显示文摘Mueller T Dieplinger B Gegenhuber A 2008Clin Chem2008,54,:1
14Hypoadiponectinemia is associated with symptonmtic atherosclerotic peripheral arterial disease显示文摘Dieplinger B Poelz W Haltmayer M 2006Clin Chem Lab Med2006,44,7:1
15Hypoadiponectinemia is associated with symptomatic atherosclerotic peripheral arterial disease 显示文摘Dieplinger B Poelz W Hahrnayer M 2006Clin Chem Lab Med2006,44,7:1
16Comparative evaluation of B - type natriuretie peptide, mid - regional pro - A - type natriuretic peptide, _mid - regional pro - adrenomedullin, and Copeptin to predict 1 - year mortality in patients with acute destabilized heart failure 显示文摘Gegenhuber A Struck J Dieplinger B et at 2007J Card Fail2007,13,1:1
17Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples显示文摘Thomas Mueller Alfons Gegenhuber Benjamin Dieplinger Werner Poelz Meinhard Haltmayer 2004Clinical Chemistry and Laboratory Medicine2004,,8:1
18Plasma B-type natriuretic peptide in patients with pleural effusions:preliminary observations显示文摘Gegenhuber A Mueller T Dieplinger B 2006Chest2006,129,2:1
19Serum total 8-iso-prostaglandin F2alpha:a new and independent predictor of peripheral arterial disease 显示文摘MUELLER T DIEPLINGER B GEGENHU B E R A 2004J Vase Surg2004,40,:1
20Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein ( a ) are associated with symptomatic peripheral arterial disease 显示文摘Dieplinger B Lingenhel A Baumgartner N 2007Clin Chem2007,53,7:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费